Antibiotic therapy and bacterial overgrowth in intestinal microbial ecosystem: a major risk of secondary infections in newborns.
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003091:Colistin / Q000627:therapeutic use; D004756:Enterobacteriaceae Infections / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000150:complications* / Q000382:microbiology; D007422:Intestines / Q000382:microbiology*; D007709:Klebsiella / Q000145:classification / Q000302:isolation & purification; D018805:Sepsis / Q000209:etiology*; D012703:Serotyping
D000900:Anti-Bacterial Agents; D003091:Colistin